Trial
NCT06651515
A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Seraxis
Collaborators
—
Condition
Diabetes Mellitus Type 1
Intervention
Allogeneic Pancreatic Endocrine Cell Clusters
Why stopped
Study is being withdrawn for business reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-16